Mitochondrial control of glycerolipid synthesis by a PEP shuttle
Summary
bioRxiv. 2026 Mar 10:2025.12.12.693842. doi: 10.64898/2025.12.12.693842. Mitochondria provide a variety of metabolites, in addition to ATP, to meet cell-specific needs. One such metabolite is phosphoenolpyruvate (PEP), which contains a higher-energy phosphate bond than ATP and has diverse biological functions. However, how mitochondria-generated PEP is delivered to the cytosol and fulfills cell-specific requirements remains elusive. Here, we show that SLC25A35 regulates mitochondrial PEP ef
Content
# Mitochondrial control of glycerolipid synthesis by a PEP shuttle
*Published: 2026 May 14*
bioRxiv. 2026 Mar 10:2025.12.12.693842. doi: 10.64898/2025.12.12.693842.
Mitochondria provide a variety of metabolites, in addition to ATP, to meet
cell-specific needs. One such metabolite is phosphoenolpyruvate (PEP), which
contains a higher-energy phosphate bond than ATP and has diverse biological
functions. However, how mitochondria-generated PEP is delivered to the cytosol
and fulfills cell-specific requirements remains elusive. Here, we show that
SLC25A35 regulates mitochondrial PEP efflux and glyceroneogenesis in lipogenic
cells that utilize the pyruvate-to-PEP bypass. Reconstitution and structural
studies demonstrated PEP transport by SLC25A35 in a pH gradient-dependent
manner. Loss of SLC25A35 in adipocytes impaired the conversion of mitochondrial
PEP into glycerol-3-phosphate, thereby reducing glycerolipid synthesis.
Significantly, hepatic inhibition of SLC25A35 in obese mice alleviated steatosis
and improved systemic glucose homeostasis. Together, these results suggest that
mitochondria facilitate glycerolipid synthesis by providing PEP via SLC25A35,
offering lipogenic mitochondria as a target to limit glycerolipid synthesis, a
pivotal step in the pathogenesis of hepatic steatosis and type 2 diabetes.
DOI: 10.1016/j.cell.2026.02.017